Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Magócsi

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 1995
Erythrocyte lipids in triose-phosphate isomerase deficiencyS Hollán, I Dey, L Szollár, et al.
Cellular Signalling|October 17, 2001
Activation of Raf/ERK1/2 MAP kinase pathway is involved in GM-CSF-induced proliferation and survival but not in erythropoietin-induced differentiation of TF-1 cellsA Kolonics, Apáti A, J Jánossy, et al.
Annals of the New York Academy of Sciences|March 27, 2007
Reduction of Bcr-Abl function leads to erythroid differentiation of K562 cells via downregulation of ERKA Brózik, N P Casey, Cs Hegedus, et al.
British Journal of Pharmacology|September 30, 2009
Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological propertiesC Hegedus, C Ozvegy-Laczka, A Apáti, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 1995
Erythrocyte lipids in triose-phosphate isomerase deficiencyS Hollán, I Dey, L Szollár, et al.
Cellular Signalling|October 17, 2001
Activation of Raf/ERK1/2 MAP kinase pathway is involved in GM-CSF-induced proliferation and survival but not in erythropoietin-induced differentiation of TF-1 cellsA Kolonics, Apáti A, J Jánossy, et al.
Annals of the New York Academy of Sciences|March 27, 2007
Reduction of Bcr-Abl function leads to erythroid differentiation of K562 cells via downregulation of ERKA Brózik, N P Casey, Cs Hegedus, et al.
British Journal of Pharmacology|September 30, 2009
Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological propertiesC Hegedus, C Ozvegy-Laczka, A Apáti, et al.
Pageof 2